Literature DB >> 10823386

Could anti-inflammatory actions of catecholamines explain the possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients?

A Uusaro1, J A Russell.   

Abstract

OBJECTIVE: To evaluate the literature regarding antiinflammatory actions of cytokines, evaluate randomized controlled trials (RCTs) of supranormal oxygen delivery, and suggest alternative mechanism(s) for possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients.
DESIGN: Literature review using Medline and review of selected illustrative studies. MAIN
RESULTS: Catecholamines (epinephrine, norepinephrine, isoproterenol, and dopamine) in general inhibit tumor necrosis factor-alpha (TNF) production and may enhance interleukin-6 (IL-6) and IL-10 production. Phosphodiesterase inhibitors also inhibit TNF and may enhance IL-10. All studies used models (cell, animal, or humans infused with endotoxin) of sepsis. RCTs of supranormal oxygen delivery show decreased mortality in high-risk surgical patients; however, prevention or reversal of tissue hypoxia may not be the mechanism of benefit. Antiinflammatory effects of catecholamines are a potential and, to date, unexplored mechanism of the benefit of supranormal oxygen delivery in critically ill surgical patients.
CONCLUSIONS: Catecholamines may modulate cytokine response beneficially and could be a mechanism of decreased morbidity and mortality of supranormal oxygen delivery in high-risk surgical patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823386     DOI: 10.1007/s001340051153

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  8 in total

Review 1.  [Effects of dopamine on cellular and humoral immune responses in septic patients].

Authors:  G Beck; C Hanusch; P Brinkkoetter; N Rafat; J Schulte; K van Ackern; B Yard
Journal:  Anaesthesist       Date:  2005-10       Impact factor: 1.041

2.  Serum concentration of adhesion molecules in patients with delayed ischaemic neurological deficit after aneurysmal subarachnoid haemorrhage: the immunoglobulin and selectin superfamilies.

Authors:  J J Nissen; D Mantle; B Gregson; A D Mendelow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

3.  "Host tissue damage" signal ATP impairs IL-12 and IFNgamma secretion in LPS stimulated whole human blood.

Authors:  Marek Nalos; Stephen Huang; Ronald Sluyter; Alamgir Khan; Brigitte Santner-Nanan; Ralph Nanan; Anthony S McLean
Journal:  Intensive Care Med       Date:  2008-06-03       Impact factor: 17.440

4.  Vasopressors and inotropes in the treatment of human septic shock: effect on innate immunity?

Authors:  Koen J Hartemink; A B Johan Groeneveld
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

5.  Effects of Mind-Body Training on Cytokines and Their Interactions with Catecholamines.

Authors:  Joon Hwan Jang; Hye Yoon Park; Ui Soon Lee; Kyung-Jun Lee; Do-Hyung Kang
Journal:  Psychiatry Investig       Date:  2017-07-11       Impact factor: 2.505

6.  Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flow.

Authors:  Mansoor N Bangash; Nimesh S A Patel; Elisa Benetti; Massimo Collino; Charles J Hinds; Christoph Thiemermann; Rupert M Pearse
Journal:  Crit Care       Date:  2013-03-28       Impact factor: 9.097

Review 7.  Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock.

Authors:  Pierre Asfar; Daniel De Backer; Andreas Meier-Hellmann; Peter Radermacher; Samir G Sakka
Journal:  Crit Care       Date:  2003-12-29       Impact factor: 9.097

8.  The Effect of β2-Adrenoceptor Agonists on Leucocyte-Endothelial Adhesion in a Rodent Model of Laparotomy and Endotoxemia.

Authors:  Mansoor Nawaz Bangash; Tom E F Abbott; Nimesh S A Patel; Charles Johnston Hinds; Christoph Thiemermann; Rupert Mark Pearse
Journal:  Front Immunol       Date:  2020-05-21       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.